1 min read

The Health Data ‘Dream State’

Featured Image

By: Emilie Branch, Content Manager, Swoop 

How condition-specific audience segments can lift your brand beyond traditional targeting.

Katie Carr, SVP of sales at Swoop, explains how pharma brands can leverage condition-specific patient segments to connect with more relevant consumer audiences online. Carr explains why real-world health data (RWD) in conjunction with artificial intelligence (AI) is the building block of custom audiences — and how custom segments provide a better way than traditional targeting methodologies for brands to drive script lift.

 


About the Author

Emilie Branch 

Content Manager

  Emilie_Headshot_cropped2 (1)

 

Emilie has nearly a decade of experience in marketing, writing, research and strategy for the pharmaceutical industry. She has contributed to top pharmaceutical publications including American Pharmaceutical Review, European Pharmaceutical Review, Pharmaceutical Manufacturing, Manufacturing Chemist, Pharmaceutical Outsourcing, Specialty Chemicals, and Contract Pharma. Prior to joining Swoop/IPM.ai, Emilie served as Strategic Content Manager and Managing Editor for Pharma’s Almanac where she lent her voice to some of the industry’s top players including GSK, MilliporeSigma and ThermoFisher Scientific. 



Implementing Conversational AI Lifts Patient and Prescriber High-Value Activity by 825% and 400% for a Top Ten Pharma’s Neurological Drug

The Challenge 

Facing a massive growth of interest in their leading neurological treatment, a top ten pharmaceutical company sought to digitally...

Read More

Transforming How Pharma Marketers Find, Target and Engage with Patients and Providers

As healthcare marketing experiences pivotal changes, from increased privacy restrictions to differing consumer behavior, working with a reliable data...

Read More